|
Role of combined germline pharmacogenomic and somatic genomic analysis in personalized cancer therapy: Non-small cell lung cancer (NSCLC) case study. |
|
|
Employment - Companion DX |
Leadership - Companion DX |
Patents, Royalties, Other Intellectual Property - Companion DX |
|
|
Employment - Companion DX |
Leadership - Companion DX |
Patents, Royalties, Other Intellectual Property - Companion DX |
Travel, Accommodations, Expenses - Companion DX |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Castlight Health; N-of-One |
|
|
Employment - Companion DX |
Leadership - Companion DX |
Stock and Other Ownership Interests - Companion DX |
Patents, Royalties, Other Intellectual Property - Companion DX |
Travel, Accommodations, Expenses - Companion DX |